Medicare Materials

Your Results

• KFF Health News: New Alzheimer’s Drug Raises Hopes — Along With Questions

  August 17, 2023: The FDA has approved Leqembi, the first disease-modifying treatment for early-stage Alzheimer’s and a precursor condition, mild cognitive impairment. Medicare has said it will pay for the therapy. Medical centers across the coun Read More >

• KFF Health News: The Real Costs of the New Alzheimer’s Drug, Most of Which Will Fall to Taxpayers

  August 03, 2023: The first drug purporting to slow the advance of Alzheimer’s disease is likely to cost the U.S. health care system billions annually even as it remains out of reach for many of the lower-income seniors most likely to suffer from Read More >

• KFF Health News: New Weight Loss Drugs Carry High Price Tags and Lots of Questions for Seniors

  July 27, 2023: Corlee Morris has dieted throughout her adult life. After her weight began climbing in high school, she spent years losing 50 or 100 pounds then gaining it back. Morris, 78, was at her heaviest in her mid-40s, standing 5 feet 1 Read More >

• America’s Work Force Union Podcast: Federal Standard Could Solve Nationwide Nursing Home Staffing Issues

  July 21, 2023: July 21, 2023 Alliance Executive Director Rich Fiesta joined the America’s Work Force Union Podcast and discussed ongoing staffing issues at nursing homes throughout the U.S. as well as prescription drug  costs. You can Read More >

• What You Need to Know About the Drug Price Fight in Those TV Ads

  July 12, 2023: In recent months ominous ads about prescription drugs have flooded the TV airwaves. Perhaps by design, it’s not always clear who’s sponsoring the ads or why. Or, for that matter, why now? The short answer is that Congres Read More >

• KFF Health News: Why the Next Big Hope for Alzheimer’s Might Not Help Most Black Patients

  July 07, 2023: The FDA on Thursday gave full approval to what many scientists and doctors believe is the first drug to show promise of slowing the progression of Alzheimer’s disease. But while patient advocates are celebrating, critics see Read More >

• Following Merck, U.S. Chamber of Commerce, Bristol Myers Squibb and PhRMA Sue Administration Over Drug Price Negotiation

  June 26, 2023: The U.S. Chamber of Commerce, Bristol Myers Squibb and PhRMA, the drug industry’s trade association, have filed three separate lawsuits against the Biden administration to block Medicare’s authority to negotiate lower drug pri Read More >

• Merck Lawsuit Over Drug Price Negotiation Reflects Industry Greed and Disregard for Seniors and Taxpayers

  June 06, 2023: The following statement was issued by Richard Fiesta, Executive Director of the Alliance for Retired Americans, regarding Merck’s filing a lawsuit to block Medicare from negotiating lower drug prices on behalf of the American pe Read More >

• Pfizer CEO Comment on Drug Price Negotiation Reflects Industry Greed, Arrogance and Disregard for Patients

  May 12, 2023: The following statement was issued by Richard Fiesta, Executive Director of the Alliance for Retired Americans, regarding Pfizer CEO Albert Bourla’s statement that the federal government’s plans to negotiate drug prices for Me Read More >

• Biden-Harris Administration Acts to Lower Prices for 27 Drugs

  March 21, 2023: On Wednesday, the Department of Health and Human Services (HHS), through the Centers for Medicare & Medicaid Services (CMS), announced 27 prescription drugs for which Medicare Part B beneficiary coinsurances may be lower from Read More >